These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 23582448)
1. Metabolism of a potent neuroprotective hydrazide. Chiruta C; Zhao Y; Tang F; Wang T; Schubert D Bioorg Med Chem; 2013 May; 21(10):2733-41. PubMed ID: 23582448 [TBL] [Abstract][Full Text] [Related]
2. Deciphering the 'Elixir of Life': Dynamic Perspectives into the Allosteric Modulation of Mitochondrial ATP Synthase by J147, a Novel Drug in the Treatment of Alzheimer's Disease. Emmanuel IA; Olotu FA; Agoni C; Soliman MES Chem Biodivers; 2019 Jun; 16(6):e1900085. PubMed ID: 30990952 [TBL] [Abstract][Full Text] [Related]
3. The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice. Prior M; Dargusch R; Ehren JL; Chiruta C; Schubert D Alzheimers Res Ther; 2013; 5(3):25. PubMed ID: 23673233 [TBL] [Abstract][Full Text] [Related]
4. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease. Duffy AM; Hölscher C Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease. Han M; Liu Y; Tan Q; Zhang B; Wang W; Liu J; Zhang XJ; Wang YY; Zhang JM Eur J Pharmacol; 2011 Apr; 657(1-3):104-10. PubMed ID: 21316359 [TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms. Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868 [TBL] [Abstract][Full Text] [Related]
7. Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells. Pickhardt M; Larbig G; Khlistunova I; Coksezen A; Meyer B; Mandelkow EM; Schmidt B; Mandelkow E Biochemistry; 2007 Sep; 46(35):10016-23. PubMed ID: 17685560 [TBL] [Abstract][Full Text] [Related]
11. Crude caffeine reduces memory impairment and amyloid β(1-42) levels in an Alzheimer's mouse model. Chu YF; Chang WH; Black RM; Liu JR; Sompol P; Chen Y; Wei H; Zhao Q; Cheng IH Food Chem; 2012 Dec; 135(3):2095-102. PubMed ID: 22953961 [TBL] [Abstract][Full Text] [Related]
12. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease. Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767 [TBL] [Abstract][Full Text] [Related]
13. The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update. Bales KR Expert Opin Drug Discov; 2012 Apr; 7(4):281-97. PubMed ID: 22458501 [TBL] [Abstract][Full Text] [Related]
14. Metabonomic profiling of TASTPM transgenic Alzheimer's disease mouse model. Hu ZP; Browne ER; Liu T; Angel TE; Ho PC; Chan EC J Proteome Res; 2012 Dec; 11(12):5903-13. PubMed ID: 23078235 [TBL] [Abstract][Full Text] [Related]
15. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model. Faivre E; Hölscher C J Alzheimers Dis; 2013; 35(2):267-83. PubMed ID: 23568101 [TBL] [Abstract][Full Text] [Related]
16. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models. Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439 [TBL] [Abstract][Full Text] [Related]
17. Towards development of drugs targeting both amyloid and tau pathologies of Alzheimer's disease. Shin J Int J Geriatr Psychiatry; 2011 May; 26(5):546-8. PubMed ID: 21446001 [No Abstract] [Full Text] [Related]
18. Ibuprofen and lipoic acid conjugate neuroprotective activity is mediated by Ngb/Akt intracellular signaling pathway in Alzheimer's disease rat model. Zara S; De Colli M; Rapino M; Pacella S; Nasuti C; Sozio P; Di Stefano A; Cataldi A Gerontology; 2013; 59(3):250-60. PubMed ID: 23428737 [TBL] [Abstract][Full Text] [Related]
19. Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease. Luo F; Rustay NR; Ebert U; Hradil VP; Cole TB; Llano DA; Mudd SR; Zhang Y; Fox GB; Day M Neurobiol Aging; 2012 May; 33(5):933-44. PubMed ID: 20961663 [TBL] [Abstract][Full Text] [Related]
20. Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease. Feng Z; Qin C; Chang Y; Zhang JT Free Radic Biol Med; 2006 Jan; 40(1):101-9. PubMed ID: 16337883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]